Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

67 articles published Follow:
Literature Reviews

Complete Guide to GenAI-enabled Literature Review for Life Sciences: MadeAi vs. Competitors

BlogFebruary 12, 2026155Views0Likes0Comments
Every professional in the life sciences knows the feeling: literature review is challenging, time-consuming, and above all, exhausting. This essential step in research can feel like a massive hurdle, slowing down innovation and consuming countless hours. Recognizing this frustration, MadeAi developed MadeAi-LR, a powerful GenAI-enabled solution designed to transform the literature review process. It provides the…

Read More

Literature Review

Literature Reviews: How AI is Revolutionizing Systematic Research

BlogFebruary 4, 202695Views0Likes0Comments
In an era where scientific publications double every nine years and over 2.5 million new research papers are published each year, keeping your literature review up to date is nearly impossible. Enter the Living Literature Review, a significant shift that turns static research snapshots into continually evolving knowledge ecosystems. Why Traditional Literature Reviews Are Becoming…

Read More

Rare Disease

From Patient Voices to Actionable Insights: Why Social Media Listening Matters for Rare Disease Companies

BlogJanuary 30, 2026119Views0Likes0Comments
Understanding patient burden and unmet needs has always been essential in healthcare. But for rare diseases research, it is absolutely critical. When patient populations are small, heterogeneous, and often underserved, every insight carries weight. Yet traditional data sources—clinical trials, claims data, registries, and surveys—often fall short of capturing the lived reality of patients and caregivers…

Read More

Madeai webinar

2026 Predictions for AI in Life Sciences

WebinarJanuary 27, 202692Views0Likes0Comments
Missed our live session? Get the recording now! On January 22, 2026, CapeStart and MadeAi hosted an exclusive webinar featuring industry innovators sharing key predictions for AI in Life Sciences in 2026. The session explores how organizations are moving beyond experimentation and preparing for AI integration across operational, regulatory, and scientific workflows. Insights were drawn…

Read More

FDA Literature Review

FDA Literature Review Requirements: Leveraging AI into Your Literature Review Strategy

BlogJanuary 23, 202672Views0Likes0Comments
Understanding FDA Literature Review Requirements The FDA requires literature reviews to ensure that regulatory decisions are based on solid scientific evidence. This isn't just about compiling papers; it's about systematically searching, appraising, and synthesizing published data to demonstrate safety, efficacy, and compliance. These requirements span multiple domains, from drug approvals to medical devices and health…

Read More